GARRISON DAVID A

CFO bought 850 shares at $5.80 on 2024-11-25; stock -18.9% (30d), HHS down -7.2% annually, unprofitable.

CFO Garrison David A purchased 850 shares at $5.80 on 2024-11-25, expanding his holdings to 13,129 shares (+6.9% vs pre-transaction). This is the third Form 4 filing from him in seven days; he initiated five open-market purchases at HHS on 2024-11-18, followed by this transaction one week later. The timing occurs amid material headwinds: HHS trades 32.8% below its 52-week high of $8.79, has declined 18.9% over the past 30 days, and faces structural challenges including annual revenue contraction of -7.2% and negative full-year net income, with latest quarterly net income of $142.0K on revenue of $47.6M. The CFO's cross-ticker track record shows a 50.00% win rate on prior buys (90d returns), though no same-ticker outcomes are yet measurable given the recency of his five November 18 purchases. The rapid cadence and scale of accumulation merit observation given the company's profitability and growth headwinds.

CFO Garrison buys 3,904 shares for $25,637.96 across 7 transactions on 2024-11-18; holdings up 46.6%.

David A. Garrison, Chief Financial Officer of Harte Hanks Inc., executed 7 separate purchases totaling 3,904 shares for $25,637.96 on November 18, 2024, raising his holdings from 8,375 to 12,279 shares—a 46.6% increase in position size. The purchases occurred at prices ranging from $6.40 to $6.65 (blended average $6.57), while the stock currently trades at $6.36, down 27.6% from its 52-week high and 12.6% lower over the past 30 days. Garrison's prior open-market purchases at this same ticker (4 trades since May) showed mixed timing outcomes: 3 of the 4 achieved positive 30-day returns (ranging 4.4% to 8.4%), but only 2 of 4 delivered positive 90-day returns, indicating inconsistent longer-term conviction. The company's fundamentals remain stressed—annual revenue declined 7.2%, full-year net income was negative, and the latest quarterly net income was only $142,000 on $47.6M revenue—leaving unclear whether this accumulation reflects bottom-fishing or a strategic response to operational challenges.

CFO Garrison buys 4,250 shares of HHS at $7.03 avg, doubling stake to 8,375; stock down 22.4% from 52-week high.

Chief Financial Officer David A Garrison purchased 4,250 shares across 3 separate transactions on 2024-08-12 at a blended average price of $7.03, increasing his holdings by 103.0% from 4,125 to 8,375 shares. The acquisition occurred as HHS stock trades 22.4% below its 52-week high and down 18.9% over 30 days. Contextually, the company reported a net loss of $-27,834,000 in its latest quarter, annual revenue declined 7.2% year-over-year, and market capitalization stands at $49,710,864.06. The timing warrants attention: Garrison's single prior buy at HHS (2024-05-13) showed a 90-day return of -0.4%, establishing a pattern of open-market purchases in a structurally challenged operating environment.